Increased NLRC5 expression has been detected in renal cell carcinoma (Wang et al., 2019), hepatocellular carcinoma (He et al., 2016), gastric cancer (Li et al., 2018), and non-small cell lung cancer (NSCLC) (Li et al., 2015). This evidence concerns the gene NLRC5 and non-small cell lung carcinoma.